ADARx Pharmaceuticals (ADRX) Stock: Why It's Down Today
Updated Oct 20, 2026, 10:17 AM ET · intraday price
- Trading at $17.00 as of 10:17 AM ET, -3.57% vs the prior close of $17.63.
- Volume 386.82K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)
ADRX slides 3.6% to $17.00, 4 down days in a row. Trading at $17.00 (intraday, 10:17 AM ET), -3.57% vs the prior close of $17.63. Day range $16.89–$18.55, opened at $17.94.
ADRX daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — ADRX slides 3.6% to $17.00, 4 down days in a row
- Trading at $17.00 (intraday, 10:17 AM ET), -3.57% vs the prior close of $17.63. Day range $16.89–$18.55, opened at $17.94.
- Volume was 386.82K shares, 0.4x its 50-day average of 871.68K — lighter than usual.
- 52-week range $16.64–$23.21; the current price sits at 5% of that range, 26.8% below the 52-week high.
- That makes 4 straight losses.
Oct 19, 2026 — ADRX ends flat (-0.1%) to $17.63, 3 down days in a row
- Closed at $17.63, -0.11% vs the prior close of $17.65. Day range $17.05–$18.33, opened at $17.76.
- Volume was 261.99K shares, 0.3x its 50-day average of 909.79K — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 15% of that range, 24.0% below the 52-week high.
- That makes 3 straight losses.
Oct 16, 2026 — ADRX ends flat (-0.3%) to $17.65
- Closed at $17.65, -0.28% vs the prior close of $17.70. Day range $17.50–$18.60, opened at $17.73.
- Volume was 247.13K shares, 0.3x its 50-day average of 953.97K — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 15% of that range, 24.0% below the 52-week high.
Oct 15, 2026 — ADRX dips 0.7% to $17.70
- Closed at $17.70, -0.73% vs the prior close of $17.83. Day range $17.50–$18.33, opened at $17.75.
- Volume was 283.40K shares, 0.3x its 50-day average of 1.00M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 16% of that range, 23.7% below the 52-week high.
Oct 14, 2026 — ADRX rises 0.7% to $17.83
- Closed at $17.83, +0.73% vs the prior close of $17.70. Day range $17.31–$18.28, opened at $17.72.
- Volume was 285.50K shares, 0.3x its 50-day average of 1.06M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 18% of that range, 23.2% below the 52-week high.
Oct 13, 2026 — ADRX dips 1.5% to $17.70
- Closed at $17.70, -1.50% vs the prior close of $17.97. Day range $17.57–$18.82, opened at $18.00.
- Volume was 221.00K shares, 0.2x its 50-day average of 1.13M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 16% of that range, 23.7% below the 52-week high.
Oct 12, 2026 — ADRX rises 1.1% to $17.97, 3 up days in a row
- Closed at $17.97, +1.07% vs the prior close of $17.78. Day range $17.57–$18.75, opened at $17.78.
- Volume was 350.80K shares, 0.3x its 50-day average of 1.20M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 20% of that range, 22.6% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — ADRX rises 0.6% to $17.78
- Closed at $17.78, +0.57% vs the prior close of $17.68. Day range $17.06–$18.19, opened at $17.70.
- Volume was 688.50K shares, 0.6x its 50-day average of 1.25M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 17% of that range, 23.4% below the 52-week high.
Oct 8, 2026 — ADRX rises 2.0% to $17.68
- Closed at $17.68, +2.02% vs the prior close of $17.33. Day range $16.64–$18.10, opened at $17.13.
- Volume was 420.20K shares, 0.3x its 50-day average of 1.34M — lighter than usual.
- 52-week range $16.64–$23.21; today's close sits at 16% of that range, 23.8% below the 52-week high.
Oct 7, 2026 — ADRX slides 6.7% to $17.33
- Closed at $17.33, -6.73% vs the prior close of $18.58. Day range $17.20–$18.70, opened at $18.33.
- Volume was 705.60K shares, 0.5x its 50-day average of 1.42M — lighter than usual.
- 52-week range $17.20–$23.21; today's close sits at 2% of that range, 25.3% below the 52-week high.
Oct 6, 2026 — ADRX dips 2.5% to $18.58
- Closed at $18.58, -2.47% vs the prior close of $19.05. Day range $18.01–$19.57, opened at $19.05.
- Volume was 1.03M shares, 0.7x its 50-day average of 1.47M.
- 52-week range $17.30–$23.21; today's close sits at 22% of that range, 19.9% below the 52-week high.
Oct 5, 2026 — ADRX jumps 4.4% to $19.05
- Closed at $19.05, +4.38% vs the prior close of $18.25. Day range $17.30–$19.40, opened at $18.25.
- Volume was 913.90K shares, 0.6x its 50-day average of 1.57M — lighter than usual.
- 52-week range $17.30–$23.21; today's close sits at 30% of that range, 17.9% below the 52-week high.
Oct 2, 2026 — ADRX slides 6.6% to $18.25, 3 down days in a row
- Closed at $18.25, -6.60% vs the prior close of $19.54. Day range $17.85–$19.53, opened at $19.31.
- Volume was 937.00K shares, 0.6x its 50-day average of 1.69M — lighter than usual.
- 52-week range $17.85–$23.21; today's close sits at 7% of that range, 21.4% below the 52-week high.
- That makes 3 straight losses.
ADRX bull case vs bear case (from the data)
- Insiders made 25 open-market purchases in the last 12 months.
- No clear negative signal in the price trend, filings or insider data right now.
ADRX latest news & SEC filings
Every SEC filing by or about ADRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chimovits Erez converted 7,127,019 shares on Sep 28, 2026; now holds 7,127,019
- Chimovits Erez converted 1,333,975 shares on Sep 28, 2026; now holds 8,460,994
- Chimovits Erez converted 513,067 shares on Sep 28, 2026; now holds 8,974,061
- Chimovits Erez converted 256,448 shares on Sep 28, 2026; now holds 9,230,509
- Chimovits Erez bought 61,516 shares at $17.00 (≈$1.05M) on Sep 28, 2026; now holds 9,292,025
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gordon Carl L converted 10,690,530 shares on Sep 28, 2026; now holds 10,690,530
- Gordon Carl L converted 2,000,962 shares on Sep 28, 2026; now holds 12,691,492
- Gordon Carl L converted 769,601 shares on Sep 28, 2026; now holds 13,461,093
- Gordon Carl L converted 564,187 shares on Sep 28, 2026; now holds 14,025,280
- Gordon Carl L bought 300,249 shares at $17.00 (≈$5.10M) on Sep 28, 2026; now holds 14,325,529
- Gordon Carl L converted 7,127,019 shares on Sep 28, 2026; now holds 7,127,019
- …plus 5 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc converted 10,690,530 shares on Sep 28, 2026; now holds 10,690,530
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc converted 2,000,962 shares on Sep 28, 2026; now holds 12,691,492
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc converted 769,601 shares on Sep 28, 2026; now holds 13,461,093
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc converted 564,187 shares on Sep 28, 2026; now holds 14,025,280
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc bought 300,249 shares at $17.00 (≈$5.10M) on Sep 28, 2026; now holds 14,325,529
- Orbimed Advisors Llc & Orbimed Capital Gp Vii Llc & Orbimed Israel Gp Ii, L.P. & Orbimed Advisors Israel Ii Ltd & Orbimed Genesis Gp Llc converted 7,127,019 shares on Sep 28, 2026; now holds 7,127,019
- …plus 5 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sr One Capital Management, Llc converted 3,334,938 shares on Sep 28, 2026; now holds 3,334,938
- Sr One Capital Management, Llc converted 1,113,666 shares on Sep 28, 2026; now holds 4,448,604
- Sr One Capital Management, Llc converted 512,897 shares on Sep 28, 2026; now holds 4,961,501
- Sr One Capital Management, Llc bought 592,593 shares at $17.00 (≈$10.07M) on Sep 28, 2026; now holds 5,554,094
- Sr One Capital Management, Llc converted 1,538,691 shares on Sep 28, 2026; now holds 1,538,691
- Sr One Capital Management, Llc bought 414,814 shares at $17.00 (≈$7.05M) on Sep 28, 2026; now holds 1,953,505
- …plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- George Simeon converted 3,334,938 shares on Sep 28, 2026; now holds 3,334,938
- George Simeon converted 1,113,666 shares on Sep 28, 2026; now holds 4,448,604
- George Simeon converted 512,897 shares on Sep 28, 2026; now holds 4,961,501
- George Simeon bought 592,593 shares at $17.00 (≈$10.07M) on Sep 28, 2026; now holds 5,554,094
- George Simeon converted 1,538,691 shares on Sep 28, 2026; now holds 1,538,691
- George Simeon bought 414,814 shares at $17.00 (≈$7.05M) on Sep 28, 2026; now holds 1,953,505
- …plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 8,908,775 shares on Sep 28, 2026; now holds 8,908,775
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 1,667,469 shares on Sep 28, 2026; now holds 10,576,244
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 513,067 shares on Sep 28, 2026; now holds 11,089,311
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 153,868 shares on Sep 28, 2026; now holds 11,243,179
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 307,738 shares on Sep 28, 2026; now holds 307,738
- Lav Biosciences Fund V, L.P. & Lav Fund Vi Opportunities, L.P. & Lav Fund Vi, L.P. converted 307,738 shares on Sep 28, 2026; now holds 307,738
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 8.01 — Reported other events the company considers important.
Sep 28, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 24, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 24, 2026 · Form S-1MEF — S-1MEF filing
S-1MEF filing
Things to know before you trade ADRX
- How much it moves: over the last 20 sessions the average daily move was 2.51% (largest 6.7%).
- Liquidity: about 844.75K shares (≈$14.36M) trade per day on average.
- 52-week position: $17.00 vs a range of $16.64–$23.21 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Carl L Gordon bought 300,249 shares on Sep 28, 2026.
- Latest filings: 8-K Sep 28, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ADRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 17.94 | 18.55 | 16.89 | 17.00 | 386.82K |
| Oct 19, 2026 | 17.76 | 18.33 | 17.05 | 17.63 | 262.00K |
| Oct 16, 2026 | 17.73 | 18.60 | 17.50 | 17.65 | 247.10K |
| Oct 15, 2026 | 17.75 | 18.33 | 17.50 | 17.70 | 283.40K |
| Oct 14, 2026 | 17.72 | 18.28 | 17.31 | 17.83 | 285.50K |
| Oct 13, 2026 | 18.00 | 18.82 | 17.57 | 17.70 | 221.00K |
| Oct 12, 2026 | 17.78 | 18.75 | 17.57 | 17.97 | 350.80K |
| Oct 9, 2026 | 17.70 | 18.19 | 17.06 | 17.78 | 688.50K |
| Oct 8, 2026 | 17.13 | 18.10 | 16.64 | 17.68 | 420.20K |
| Oct 7, 2026 | 18.33 | 18.70 | 17.20 | 17.33 | 705.60K |
| Oct 6, 2026 | 19.05 | 19.57 | 18.01 | 18.58 | 1.03M |
| Oct 5, 2026 | 18.25 | 19.40 | 17.30 | 19.05 | 913.90K |
| Oct 2, 2026 | 19.31 | 19.53 | 17.85 | 18.25 | 937.00K |
| Oct 1, 2026 | 19.99 | 20.77 | 18.99 | 19.54 | 962.20K |
| Sep 30, 2026 | 20.65 | 21.61 | 19.23 | 19.94 | 788.80K |
| Sep 29, 2026 | 19.90 | 21.50 | 19.51 | 20.64 | 1.30M |
| Sep 28, 2026 | 19.00 | 21.77 | 18.50 | 20.09 | 1.21M |
| Sep 25, 2026 | 22.10 | 23.21 | 19.00 | 19.35 | 4.21M |
About ADARx Pharmaceuticals
ADARx Pharmaceuticals (ADRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1802369.
ADRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Erez Chimovits | Director | Sep 30, 2026 |
| Carl L Gordon | Director | Sep 30, 2026 |
| Simeon George | Director | Sep 29, 2026 |
| Ying Huang | Director | Sep 24, 2026 |
| Zhen Li | President and CEO | Sep 28, 2026 |
| Advisors Llc Orbimed | Director | Sep 30, 2026 |
| Advisors Israel Ii Ltd Orbimed | Director | Sep 30, 2026 |
| Capital Gp Vii Llc Orbimed | Director | Sep 30, 2026 |
| Genesis Gp Llc Orbimed | Director | Sep 30, 2026 |
| Israel Gp Ii, L.P. Orbimed | Director | Sep 30, 2026 |
| Mary Tagliaferri | Director | Sep 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert William Ackles | Chief People Officer | Sep 28, 2026 |
| Ryan Fisk | CFO and CBO | Sep 28, 2026 |
| Zhen Li | President and CEO | Sep 28, 2026 |
| Alan Robert Macleod | Chief Scientific Officer | Sep 28, 2026 |
| Rui (Nmn) Zhu | Chief Technology Officer | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Carl L Gordon | Buy | 300,249 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 588,235 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 300,249 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 588,235 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 300,249 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 588,235 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 300,249 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 588,235 | $17.00 |
| Sep 28, 2026 | Carl L Gordon | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Erez Chimovits | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Erez Chimovits | Buy | 61,516 | $17.00 |
| Sep 28, 2026 | Erez Chimovits | Buy | 61,516 | $17.00 |
ADRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ADRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ADRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 10:17 AM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.